IR 777Alternative Names: Crohn's disease vaccine - Immune Response BioPharma; CrohnsVax; IR-777 vaccine - Immune Response BioPharma; IR777
Latest Information Update: 24 Aug 2016
At a glance
- Originator Immune Response BioPharma
- Class Vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Crohn's disease
Most Recent Events
- 24 Aug 2016 Phase-I clinical trials in Crohn's disease (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Crohn's-disease in USA (Parenteral)